Similarly, fetuin A and vitronectin which were reduced in SMA mice in our study were previously shown to have a negative correlation with function in SMA patients (i.e. the levels of protein were reduced in association with increased function) [54, 55]. The gene discussed is AHSG; the disease is proximal spinal muscular atrophy.